Form 4 Filing for Michael Allen Jerman

Michael Allen Jerman, a director at Alaunos Therapeutics, Inc. (TCRT), acquired 20,990 shares of common stock on October 6, 2026. These shares were issued in lieu of board fees. The acquisition price was $0.7444 per share, resulting in a post-transaction ownership of 44,749 shares. This transaction is classified as direct ownership.